|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash | |||||
| Restricted cash | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other | |||||
| Total current assets | |||||
| Property, plant and equipment | |||||
| Intangible assets | |||||
| Goodwill | |||||
| Right-of-use assets | |||||
| Total assets | |||||
| Accounts payable and accrued liabilities | |||||
| Current portion of loans payable | |||||
| Current portion of lease liabilities | |||||
| Current portion of shareholder loan | |||||
| Other payables | |||||
| Non-controlling interest loans | |||||
| Total current liabilities | |||||
| Loans payable | |||||
| Lease liabilities | |||||
| Shareholder loan | |||||
| Total liabilities | |||||
| Common shares | |||||
| Contributed surplus | |||||
| Deficit | |||||
| Total shareholders' equity excluding non-controlling interest | |||||
| Non-controlling interest | |||||
| Total shareholders' (deficit) equity | |||||
| Assets | |||||
| Current assets: | |||||
| Cash | |||||
| Restricted cash | |||||
| Accounts receivable, net (note 19(b)) | |||||
| Prepaid expenses and other | |||||
| Total current assets | |||||
| Property, plant and equipment (note 5) | |||||
| Intangible assets (note 6) | |||||
| Goodwill | |||||
| Finance right-of-use assets (note 7(a)) | |||||
| Operating right-of-use assets (note 7(b)) | |||||
| Total assets | |||||
| Liabilities and Shareholders' Deficit | |||||
| Current liabilities: | |||||
| Accounts payable and accrued liabilities (note 8) | |||||
| Current portion of loans payable (note 9(a)) | |||||
| Current portion of finance lease liabilities (note 7(a)) | |||||
| Current portion of operating lease liabilities (note 7(b)) | |||||
| Current portion of shareholder loans (note 10) | |||||
| Other payables (note 11) | |||||
| Non-controlling interest loans (note 9(b)) | |||||
| Deferred and contingent consideration (note 12) | |||||
| Advance for research collaboration (note 13) | |||||
| Total current liabilities | |||||
| Loans payable (note 9(a)) | |||||
| Finance lease liabilities (note 7(a)) | |||||
| Operating lease liabilities (note 7(b)) | |||||
| Shareholder loans (note 10) | |||||
| Total liabilities | |||||
| Shareholders' deficit: | |||||
| Common shares (note 14) | |||||
| Contributed surplus (note 15) | |||||
| Deficit | |||||
| Total shareholders' deficit excluding non-controlling interest | |||||
| Non-controlling interest (note 23) | |||||
| Total shareholders' deficit | |||||
| Total liabilities and shareholders' deficit |
Loading...